Rao, K N Purnachandra <br/><br/>
Co-expression of recombinant human CYP2C9 with human cytochrome P450 reductase in protease deficient S. cerevisiae strain at a higher scale yields an enzyme of higher specific activity.  [electronic resource] 

 -  Drug metabolism letters  Dec 2010 
 - 246-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1874-0758 
<br/><br/><label>Standard No.: </label>10.2174/187231210792928233  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Cytochrome P-450 CYP2C9<br/>Cytochromes b5--genetics<br/>Fluorescein--metabolism<br/>Humans<br/>Kinetics<br/>Microsomes--enzymology<br/>NADPH-Ferrihemoprotein Reductase--biosynthesis<br/>Peptide Hydrolases--deficiency<br/>Recombinant Proteins--metabolism<br/>Saccharomyces cerevisiae--enzymology<br/>Substrate Specificity<br/>Sulfaphenazole--pharmacology